In-Depth Research On:
AVEO Pharmaceuticals, Inc. (AVEO)

Sign Up Now to Download a Free Research Report on AVEO

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals shares gained 0.39 percent to close at $2.55 a share Friday. The stock traded between $2.23 and $2.56 on volume of 1.17 million shares traded. The company has received a subpoena from the U.S. Securities and Exchange Commission for documents related to its experimental kidney cancer drug. Shares of AVEO Pharmaceuticals have fallen approximately 68.3 percent year-to-date.

Going forward ... (see research report)


RESEARCH REPORT ON AVEO
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on